Poland· PL-100112894
Jodi Gel 10%
A povidone-iodine product containing povidonum iodinatum, registered in Poland by GEMIPHARMA Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Povidone-iodine is registered in 12 of 19 countries.
Countries holding a registration under ATC D08AG02 (povidone-iodine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Povidone-iodine · ATC D08AG02
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Povidonum iodinatum
- Manufacturer
- GEMIPHARMA Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D08AG02
- ATC class
- Povidone-iodine
- Defined daily dose
- 0.4 g, T
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990985418
- gtin05909990985432
- gtin05909990985425
- gtin05909990985449
- gtin05909990985456
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for povidone-iodine.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Povidone-iodine · interactions on record
1 record
- 1 moderate
Most severe, free to view
- LithiumN05AN01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Povidone-iodine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainBETADINE GEL 100 MG/G GELCooper Consumer Health B.V.
- United States3M Skin and Nasal AntisepticSolventum US LLC
- CzechiaBETADINELAVIPHARM S.A., Peania, Attica
- Japanポビドンヨード吉田製薬
- United KingdomBetadine 1% gargle and mouthwashMolnlycke Health Care Ltd
- BelgiumBraunoderm 0.9 % - 45 %B. Braun Melsungen
- FranceBETADINE 1 %, solution pour gargarisme/bain de boucheCOOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- NetherlandsBetadine desinfectiedoekjes, geïmpregneerde doek met oplossing voor cutaan gebruik 350 mgCooper Consumer Health B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6a24854-201f-4efb-a919-438431a92327 GET /v1/drugs/e6a24854-201f-4efb-a919-438431a92327?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel",
"source": "urpl",
"strength": "100 mg/g",
"packaging": "05909990985418 ¦ OTC ¦ 20392\n1 tuba 10 ml\n05909990985432 ¦ OTC ¦ Skasowane ¦ 20393\n1 butelka 20 ml\n05909990985425 ¦ OTC ¦ Skasowane ¦ 20394\n1 tuba 100 ml\n05909990985449 ¦ OTC ¦ Skasowane ¦ 20395\n1 butelka 100 ml\n05909990985456 ¦ OTC ¦ 20396\n1 butelka 1000 ml",
"substance": "Polyvidonum iodinatum 10 g",
"common_name": "Povidonum iodinatum",
"pl_product_id": "100112894",
"pozwolenie_nr": "09854",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about povidone-iodine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.